Fosun Founded in Shanghai
Fosun was founded in Shanghai by Guo Guangchang, Liang Xinjun, Wang Qunbin, and Fan Wei, with initial capital from a market research business. #business #founding
Fosun International is a Chinese multinational conglomerate founded in 1992 by Guo Guangchang and others. It has grown through strategic acquisitions in healthcare, tourism, insurance, and technology, becoming a globally recognized investment group.
Fosun was founded in Shanghai by Guo Guangchang, Liang Xinjun, Wang Qunbin, and Fan Wei, with initial capital from a market research business. #business #founding
Fosun entered the pharmaceutical industry by investing in traditional Chinese medicine and later establishing Fosun Pharma. #healthcare #pharmaceuticals
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was listed on the Shanghai Stock Exchange, raising capital for expansion. #IPO #pharmaceuticals
Fosun expanded into real estate and steel industries, establishing Fosun Property and investing in Nanjing Iron and Steel. #diversification #realestate
Fosun International Limited was incorporated in Hong Kong as the holding company for the group's operations. #corporate #structure
Fosun International held its initial public offering on the Hong Kong Stock Exchange, raising approximately HK$12.8 billion. #IPO #HongKong
Fosun acquired a stake in Yongan Property Insurance, marking its entry into the insurance sector. #insurance #acquisition
Fosun Pharma acquired a 51% stake in China Pharmaceutical Group to strengthen its drug distribution network. #pharmaceuticals #M&A
Fosun acquired a 7.1% stake in Club Méditerranée, beginning its foray into global tourism. #tourism #investment
Fosun acquired 80% of Portuguese insurer Fidelidade for €1 billion, a major step in international insurance. #insurance #international
Fosun acquired a significant stake in Folli Follie, a Greek luxury fashion brand, expanding its consumer goods portfolio. #luxury #acquisition
Fosun completed a €939 million takeover of Club Med, taking the French resort operator private. #tourism #M&A
Fosun acquired iron ore assets in Canada, diversifying into natural resources. #mining #resources
Fosun invested in St. Jude Medical (now Abbott) to expand in medical devices. #healthcare #medicaldevices
Fosun consolidated its tourism assets under Fosun Tourism Group, including Club Med and Atlantis resorts. #tourism #restructuring
Fosun Pharma acquired a 74% stake in Gland Pharma, an Indian injectable drug maker, for $1.26 billion. #pharmaceuticals #India
Fosun Health acquired Lingang Healthcare in Shanghai to expand its hospital network. #healthcare #expansion
Fosun reported annual revenues of RMB 143 billion, driven by its pharmaceutical and tourism segments. #financials #growth
Fosun Pharma partnered with BioNTech to develop and distribute the COVID-19 vaccine in China. #healthcare #vaccine
Fosun Tourism Group filed for a Hong Kong IPO, but later withdrew due to market conditions. #tourism #IPO
Fosun's high debt levels led to credit rating downgrades and asset sales, including $6.7 billion from asset disposals. #debt #restructuring
Fosun sold its 60% stake in Nanjing Iron and Steel for about RMB 13.6 billion to reduce debt. #assetdisposal #steel
Following leadership changes, Fosun appointed new board members to focus on core businesses and deleveraging. #leadership #corporate
Fosun continues to focus on healthcare and tourism while divesting non-core assets, aiming for sustainable growth. #strategy #future